Evaluation of discharge prescriptions for secondary prevention in patients with acute coronary syndromes in Iraq

Nassr, Ola Ali; Forsyth, Paul; Johnson, Chris F.
Pharm. pract. (Granada, Internet) ; 17(1): 0-0, ene.-mar. 2019. tab
Artículo en Inglés | IBECS (España) | ID: ibc-184610

Documentos relacionados

  1. Underuse of beta-blockers by patients with COPD and co-morbid acute coronary syndrome: A nationwide follow-up study in New Zealand.
  2. Management quality indicators and in-hospital mortality among acute coronary syndrome patients admitted to tertiary hospitals in Ethiopia: prospective observational study.
  3. [Influence of chronic obstructive pulmonary disease on hospital outcomes of percutaneous coronary interventions in patients with acute coronary syndrome].
  4. [First Moscow "snapshot" register of acute coronary syndromes: characteristics of patients, management and outcomes during hospitalization].
  5. A Risk Model to Predict Statin Non-Adherence Following an Acute Coronary Syndrome.
  6. Early ICD implantation in cardiac arrest survivors with acute coronary syndrome - predictors of implantation, ICD-therapy and long-term survival.
  7. Major Bleeding Events Are Stronger Predictors of Long-Term Mortality Than Coronary Events in Secondary Prevention Therapy for Ischaemic Heart Disease.
  8. Short Sleep Duration After Hospital Evaluation for Acute Coronary Syndrome Is Associated With Increased Risk of 6-Month Readmission.
  9. Increases in early discharge following acute coronary syndrome hospitalisations and associated clinical outcomes in New Zealand between 2006 and 2015: ANZACS-QI-43 study.
  10. Analysis of situation of acute coronary syndrome based on the date of the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) project: single-centre observational study.